ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

Bush Appoints Kripke To President’s Cancer Panel

February 21, 2003

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

In the States: Arizona Approves Legislation on Patient Care Costs in Trials

May 5, 2000

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

June 21, 2002

Program Project Guidelines Available

October 27, 1995

Cooperative Groups: PCPT Enrollment Complete, Three Years To The Day rial Began

December 13, 1996